These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6125367)

  • 1. A new urinary metabolite of clofazimine in leprosy patients.
    Feng PC; Fenselau CC; Jacobson RR
    Drug Metab Dispos; 1982; 10(3):286-8. PubMed ID: 6125367
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of clofazimine in leprosy patients.
    Feng PC; Fenselau CC; Jacobson RR
    Drug Metab Dispos; 1981; 9(6):521-4. PubMed ID: 6120809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of clofazimine metabolites in humans by HPLC-electrospray mass spectrometry.
    Krishna DR; Mamidi RN; Hofmann U; Prabhakar CM
    Arzneimittelforschung; 1997 Mar; 47(3):303-6. PubMed ID: 9105550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
    Balakrishnan ; Seshadri PS
    Lepr India; 1981 Jan; 53(1):17-22. PubMed ID: 7218762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of intracellular deposition of the anti-leprosy drug clofazimine in mouse spleen using laser microprobe mass analysis.
    Vandeputte D; Jacob W; Van Grieken R; Boddingius J
    Biol Mass Spectrom; 1993 Apr; 22(4):221-5. PubMed ID: 8481409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine in pregnancy complicated by leprosy.
    Farb H; West DP; Pedvis-Leftick A
    Obstet Gynecol; 1982 Jan; 59(1):122-3. PubMed ID: 7078842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofazimine in lepra (ENL) reaction, one year clinical trial.
    Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
    Lepr India; 1983 Apr; 55(2):265-77. PubMed ID: 6355652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on drug interactions.
    Venkatesan K; Bharadwaj VP; Ramu G; Desikan KV
    Lepr India; 1980 Apr; 52(2):229-35. PubMed ID: 7453137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of one year clofazimine therapy on autonomic functions in lepromatous leprosy with lepra (ENL) reaction.
    Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
    Lepr India; 1983 Apr; 55(2):278-85. PubMed ID: 6688841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastro-intestinal side effects of clofazimine.
    Lal S; Garg BR; Hameedulla A
    Lepr India; 1981 Apr; 53(2):285-8. PubMed ID: 7253579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy trial in paucibacillary leprosy using clofazimine.
    Katoch K; Natarajan M; Katoch VM; Singh HB; Bhatia AS
    Indian J Lepr; 1999; 71(3):311-24. PubMed ID: 10626237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.
    Pais AV; Pereira S; Garg I; Stephen J; Antony M; Inchara YK
    Lepr Rev; 2004 Jun; 75(2):171-6. PubMed ID: 15282969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible incompatibility of dapsone with clofazimine in the treatment of patients with erythema nodosum leprosum.
    Imkamp FM; Anderson R; Gatner EM
    Lepr Rev; 1982 Jun; 53(2):148-9. PubMed ID: 7098753
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of neuritis among paucibacillary leprosy patients during treatment and surveillance.
    John AS
    Indian J Lepr; 2004; 76(3):215-22. PubMed ID: 15835606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of antileprotic agents (clofazimine) on the phagocytosis of leprotic patients and possible etiological explanation of Hansen's disease].
    Niwa Y; Ozaki M
    Rinsho Ketsueki; 1983 Aug; 24(8):1039-48. PubMed ID: 6645072
    [No Abstract]   [Full Text] [Related]  

  • 20. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.